| Typicality: | 0.503 |
| Saliency: | 0.213 |
| with clinical research organizations | 8 | other |
| up to termination | 3 | temporal |
| with cros | 2 | other |
| expense → be incurred under → agreement | 8 |
| expense → be incurred under → this agreement | 3 |
| negative | neutral | positive |
| 0.316 | 0.655 | 0.029 |
| Raw frequency | 11 |
| Normalized frequency | 0.213 |
| Modifier score | 1.000 |
| Perplexity | 226.793 |